117 related articles for article (PubMed ID: 12049979)
1. Quantitative analysis of mannitol polymorphs. X-ray powder diffractometry--exploring preferred orientation effects.
Campbell Roberts SN; Williams AC; Grimsey IM; Booth SW
J Pharm Biomed Anal; 2002 Jun; 28(6):1149-59. PubMed ID: 12049979
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of mannitol polymorphs. FT-Raman spectroscopy.
Campbell Roberts SN; Williams AC; Grimsey IM; Booth SW
J Pharm Biomed Anal; 2002 Jun; 28(6):1135-47. PubMed ID: 12049978
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the preferred orientation of delta-mannitol crystallites in tablets.
Koivisto M; Virjonen T; Heikkilä T; Lehto VP
J Pharm Biomed Anal; 2004 Nov; 36(3):559-64. PubMed ID: 15522530
[TBL] [Abstract][Full Text] [Related]
4. Particle size dependence of polymorphism in spray-dried mannitol.
Lee YY; Wu JX; Yang M; Young PM; van den Berg F; Rantanen J
Eur J Pharm Sci; 2011 Sep; 44(1-2):41-8. PubMed ID: 21699976
[TBL] [Abstract][Full Text] [Related]
5. Physicochemical characterization of D-mannitol polymorphs: the challenging surface energy determination by inverse gas chromatography in the infinite dilution region.
Cares-Pacheco MG; Vaca-Medina G; Calvet R; Espitalier F; Letourneau JJ; Rouilly A; Rodier E
Int J Pharm; 2014 Nov; 475(1-2):69-81. PubMed ID: 25151549
[TBL] [Abstract][Full Text] [Related]
6. The improved compaction properties of mannitol after a moisture-induced polymorphic transition.
Yoshinari T; Forbes RT; York P; Kawashima Y
Int J Pharm; 2003 Jun; 258(1-2):121-31. PubMed ID: 12753759
[TBL] [Abstract][Full Text] [Related]
7. Quantification of gabapentin polymorphs in gabapentin/excipient mixtures using solid state
Tinmanee R; Larsen SC; Morris KR; Kirsch LE
J Pharm Biomed Anal; 2017 Nov; 146():29-36. PubMed ID: 28843174
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical characterization of meloxicam-mannitol binary systems.
Nassab PR; Rajkó R; Szabó-Révész P
J Pharm Biomed Anal; 2006 Jun; 41(4):1191-7. PubMed ID: 16621418
[TBL] [Abstract][Full Text] [Related]
9. Quantitative determination of famotidine polymorphs: X-ray powder diffractometric and Raman spectrometric study.
Német Z; Kis GC; Pokol G; Demeter A
J Pharm Biomed Anal; 2009 Feb; 49(2):338-46. PubMed ID: 19131203
[TBL] [Abstract][Full Text] [Related]
10. Identification of Polymorphic Forms of Active Pharmaceutical Ingredient in Low-Concentration Dry Powder Formulations by Synchrotron X-Ray Powder Diffraction.
Egusa K; Okazaki F; Schiewe J; Werthmann U; Wolkenhauer M
Drugs R D; 2017 Sep; 17(3):413-418. PubMed ID: 28905245
[TBL] [Abstract][Full Text] [Related]
11. Quantitative determination of polymorphic composition in intact compacts by parallel-beam X-ray powder diffractometry.
Cao W; Bates S; Peck GE; Wildfong PL; Qiu Z; Morris KR
J Pharm Biomed Anal; 2002 Nov; 30(4):1111-9. PubMed ID: 12408902
[TBL] [Abstract][Full Text] [Related]
12. Influence of sample characteristics on quantification of carbamazepine hydrate formation by X-ray powder diffraction and Raman spectroscopy.
Tian F; Zhang F; Sandler N; Gordon KC; McGoverin CM; Strachan CJ; Saville DJ; Rades T
Eur J Pharm Biopharm; 2007 Jun; 66(3):466-74. PubMed ID: 17257816
[TBL] [Abstract][Full Text] [Related]
13. Antisolvent crystallization of pharmaceutical excipients from aqueous solutions and the use of preferred orientation in phase identification by powder X-ray diffraction.
Crisp JL; Dann SE; Blatchford CG
Eur J Pharm Sci; 2011 Apr; 42(5):568-77. PubMed ID: 21382490
[TBL] [Abstract][Full Text] [Related]
14. Limits of visual detection for finasteride polymorphs in prepared binary mixtures: analysis by X-ray powder diffraction.
Antonio SG; Paiva-Santos CO; Bezzon VDN
J Pharm Sci; 2014 Nov; 103(11):3567-3575. PubMed ID: 25197019
[TBL] [Abstract][Full Text] [Related]
15. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
Bellur Atici E; Karlığa B
J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
[TBL] [Abstract][Full Text] [Related]
16. The Influence of Mannitol Hemihydrate on the Secondary Drying Dynamics of a Protein Formulation: A Case Study.
Srinivasan JM; Wegiel LA; Hardwick LM; Nail SL
J Pharm Sci; 2017 Dec; 106(12):3583-3590. PubMed ID: 28867201
[TBL] [Abstract][Full Text] [Related]
17. Characterization and crystal structure of D-mannitol hemihydrate.
Nunes C; Suryanarayanan R; Botez CE; Stephens PW
J Pharm Sci; 2004 Nov; 93(11):2800-9. PubMed ID: 15368529
[TBL] [Abstract][Full Text] [Related]
18. Determination of the polymorphic forms of bicifadine hydrochloride by differential scanning calorimetry-thermogravimetric analysis, X-ray powder diffraction, attenuated total reflectance-infrared spectroscopy, and attenuated total reflectance-near-infrared spectroscopy.
McArdle P; Gilligan K; Cunningham D; Ryder A
Appl Spectrosc; 2005 Nov; 59(11):1365-71. PubMed ID: 16316514
[TBL] [Abstract][Full Text] [Related]
19. Terahertz spectroscopy to identify the polymorphs in freeze-dried Mannitol.
Chakkittakandy R; Corver JA; Planken PC
J Pharm Sci; 2010 Feb; 99(2):932-40. PubMed ID: 19718772
[TBL] [Abstract][Full Text] [Related]
20. Raman mapping of mannitol/lysozyme particles produced via spray drying and single droplet drying.
Pajander JP; Matero S; Sloth J; Wan F; Rantanen J; Yang M
Pharm Res; 2015 Jun; 32(6):1993-2002. PubMed ID: 25504535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
